Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
15000 participants
OBSERVATIONAL
2018-11-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Developing a national hierarchical health management network platform for middle-aged and elderly osteoporosis patients. With this platform, the data of medical records, laboratory results would be shared between medical institutions. And primary hospitals can refer the patients to the nearest medical centre for advanced auxiliary examinations and diagnosis.
2. Establishing a muti-level hospital collaboration, doctor-patient interaction management model of osteoporosis.
3. To explore and establish a early warning and screening pathways for osteoporosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chinese Osteoporotic Fracture Registration Network Platform
NCT05339425
Multicenter Cohort Study on Osteoporosis
NCT02958020
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NCT05866029
Epidemiological Study of Osteoporosis in the Elderly Population of Shandong Province
NCT06915935
Prevalence and Predictors of Osteoporosis in the Beijing's Urban Population
NCT01476150
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention would be taken
No intervention would be taken. Patients enrolled would be managed by this tiered diagnosis and treatment system and receive standard treatment according to clinical guidelines of osteoporosis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Conform to the diagnosis of osteoporosis or osteopenia as followings:
1. Bone mineral density measured by dual-energy X-ray absorptiometry show a T-score ≤ -1.0 at neck of femur or total hip or lumber 1-4 OR
2. Have at least once major osteoporotic fracture
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
The propotion of patients treated in comliance with guidelines Xia, MD
Role: STUDY_CHAIR
Peking Union Medical College Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Beijing Friendship Hospital
Beijing, Beijing Municipality, China
Beijing Jishuitan Hospital
Beijing, Beijing Municipality, China
Beijing shijingshan hospital
Beijing, Beijing Municipality, China
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Peking University Third Hospital
Beijing, Beijing Municipality, China
Fujian Provincial Hospital
Fuzhou, Fujian, China
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
The third hospital of hebei medical university
Shijiazhuang, Hebei, China
The Second Hospital of Xiangya,Central South University
Changsha, Hunan, China
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China
The fourth hospital of jilin university
Changchun, Jilin, China
Shengjing hospital affiliated to China medical university
Shenyang, Liaoning, China
People's hospital of ningxia hui autonomous region
Yinchuan, Ninxia, China
The Sixth People's Hospital Affiliated to Shanghai Jiaotong University
Shanghai, Shanghai Municipality, China
Huadong hospital affiliated to fudan university
Shanghai, Shanghai Municipality, China
Shanghai first people's hospital affiliated to Shanghai jiaotong university
Shanghai, Shanghai Municipality, China
Tongji hospital affiliated to tongji university
Shanghai, Shanghai Municipality, China
Xi'an Red Cross hospital
Xi'an, Shannxi, China
The first affiliated hospital of shanxi medical university
Taiyuan, Shanxi, China
West China hospital of sichuan university
Chengdu, Sichuan, China
Western theater general hospital
Chengdu, Sichuan, China
Tianjin hospital
Tianjin, Tianjin Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Weibo Xia, MD
Role: primary
Hai Tang
Role: primary
Liang He
Role: primary
Hongyu Dong
Role: primary
Yu Pei
Role: primary
Chunli Song
Role: primary
Jianming Hou
Role: primary
Wen Wu
Role: primary
Yukun Li
Role: primary
Zhongjian Xie
Role: primary
Hua Lin
Role: primary
Youjia Xu
Role: primary
Yanan Huo
Role: primary
Mengmeng Zhang
Role: primary
Qin Fu
Role: primary
Jinhan Lv
Role: primary
Zhenlin Zhang
Role: primary
Qun Cheng
Role: primary
Li You
Role: primary
Keqin Zhang
Role: primary
Yuhong Zeng
Role: primary
Jin Dong
Role: primary
Decai Chen
Role: primary
Xiaolan Jin
Role: primary
Aijun Chao
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JS-1894
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.